浙江医学
浙江醫學
절강의학
ZHEJIANG MEDICAL JOURNAL
2013年
19期
1729-1732
,共4页
严秋亮%朱友根%刘栋%应延风%倪德生%毛宇飞%蒋进展
嚴鞦亮%硃友根%劉棟%應延風%倪德生%毛宇飛%蔣進展
엄추량%주우근%류동%응연풍%예덕생%모우비%장진전
肝切除术%前列腺素E1%肝功能
肝切除術%前列腺素E1%肝功能
간절제술%전렬선소E1%간공능
Hepatectomy%PGE1%Liver function
目的:探讨前列腺素E1(PGE1)对肝切除术后肝功能的保护作用及机制。方法选取118例接受肝大部切除术患者,其中A组36例(术后常规治疗),B组40例(术后常规治疗+PGE120μg/d,静脉注射,连续14d),C组42例(术中门静脉阻断再开放时行Lipo- PGE120μg门静脉灌注+B组方案)。分别检测3组患者术前与术后1、3、5、9、14、28d外周血ALT及TNF-α、IL-6、IL-10、IFN-γ水平,以及术前与术后1、7、28d门静脉血流量的变化。结果3组患者术前各指标差异均无统计学意义(均P>0.05)。术后各组患者ALT、TNF-α、IL-6、IL-10水平均明显升高,然后逐渐恢复,但B、C组升高幅度明显低于A组(均P<0.01),且恢复时间快于A组;A组IFN-γ水平在手术前后无明显改变,但B、C组在术后28d,IFN-γ水平明显持续升高(均P<0.01)。A组门静脉血流量手术前后无明显改变,而B、C组术后门静脉血流量在观察时段内明显且逐渐增高(均P<0.05)。以上所有PGE1干预引起的变化,C组均较B组明显。结论 PGE1有利于肝切除术后早期功能的恢复,其作用机制可能与调节细胞因子水平及增加门静脉血流有关。
目的:探討前列腺素E1(PGE1)對肝切除術後肝功能的保護作用及機製。方法選取118例接受肝大部切除術患者,其中A組36例(術後常規治療),B組40例(術後常規治療+PGE120μg/d,靜脈註射,連續14d),C組42例(術中門靜脈阻斷再開放時行Lipo- PGE120μg門靜脈灌註+B組方案)。分彆檢測3組患者術前與術後1、3、5、9、14、28d外週血ALT及TNF-α、IL-6、IL-10、IFN-γ水平,以及術前與術後1、7、28d門靜脈血流量的變化。結果3組患者術前各指標差異均無統計學意義(均P>0.05)。術後各組患者ALT、TNF-α、IL-6、IL-10水平均明顯升高,然後逐漸恢複,但B、C組升高幅度明顯低于A組(均P<0.01),且恢複時間快于A組;A組IFN-γ水平在手術前後無明顯改變,但B、C組在術後28d,IFN-γ水平明顯持續升高(均P<0.01)。A組門靜脈血流量手術前後無明顯改變,而B、C組術後門靜脈血流量在觀察時段內明顯且逐漸增高(均P<0.05)。以上所有PGE1榦預引起的變化,C組均較B組明顯。結論 PGE1有利于肝切除術後早期功能的恢複,其作用機製可能與調節細胞因子水平及增加門靜脈血流有關。
목적:탐토전렬선소E1(PGE1)대간절제술후간공능적보호작용급궤제。방법선취118례접수간대부절제술환자,기중A조36례(술후상규치료),B조40례(술후상규치료+PGE120μg/d,정맥주사,련속14d),C조42례(술중문정맥조단재개방시행Lipo- PGE120μg문정맥관주+B조방안)。분별검측3조환자술전여술후1、3、5、9、14、28d외주혈ALT급TNF-α、IL-6、IL-10、IFN-γ수평,이급술전여술후1、7、28d문정맥혈류량적변화。결과3조환자술전각지표차이균무통계학의의(균P>0.05)。술후각조환자ALT、TNF-α、IL-6、IL-10수평균명현승고,연후축점회복,단B、C조승고폭도명현저우A조(균P<0.01),차회복시간쾌우A조;A조IFN-γ수평재수술전후무명현개변,단B、C조재술후28d,IFN-γ수평명현지속승고(균P<0.01)。A조문정맥혈류량수술전후무명현개변,이B、C조술후문정맥혈류량재관찰시단내명현차축점증고(균P<0.05)。이상소유PGE1간예인기적변화,C조균교B조명현。결론 PGE1유리우간절제술후조기공능적회복,기작용궤제가능여조절세포인자수평급증가문정맥혈류유관。
Objective To investigate the protective effect of prostaglandin E1 (PGE1) on liver function in patients after hep-atectomy. Methods One hundred and eighteen patients scheduled to undergo major liver resection were randomly designated to group A(receiving conventional postoperative treatment n=36), group B (receiving conventional treatment plus intravenous in-jection of 20μg/d Lipo- PGE1 for 14d, n=40) and group C (undergoing portal vein infusion of 20μg Lipo- PGE1 immediately after portal vein clamping was finished during surgery plus the same regimen as group B, n=42). The levels of alanine transaminase (ALT) and cytokines TNF- α, IL- 6, IL- 10 and IFN- γin peripheral blood were measured before and 1, 3, 5, 9, 14 and 28 d after surgery, and the portal venous flow volume was also determined before and 1, 7 and 24 d after surgery. Results Al parameters among the three groups had no significant differences before surgery (al P>0.05). The levels of TNF- α, IL- 6 and IL- 10 in all groups were markedly increased after surgery and then returned to baseline gradual y, while these cytokines in groups B and C were increased significantly less and decreased shorter than those in group A (al P<0.05). The pre- and postoperative IFN- γlevels in group A showed no significant changes, but those in groups B and C were significantly increased and continued to rise until 28 d after surgery (al P<0.05).No difference was observed in portal venous flow volume before and after surgery in group A, while a continuous increase was found after surgery in groups B and C (al P<0.05). All the changes caused by PGE1 intervention were more evident in group C than those in group B. Conclusion PGE1 is beneficial for early recovery of liver function after hep-atectomy, which may be related to regulating cytokines levels and increasing the portal venous inflow.